Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Loertzer

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|May 18, 2013
[Stress incontinence in elderly women]H Loertzer, P Schneider
Anticancer Research|July 22, 2005
PSA quick test in capillary bloodH Loertzer, K Fischer, P Fornara
Anticancer Research|July 22, 2005
The use of complexed PSA for the early detection of prostate cancerK Fischer, H Loertzer, P Fornara
Der Urologe. Ausg. A|September 27, 2003
[Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis]H Loertzer, A Jurczok, S Wagner, et al.
Der Urologe. Ausg. A|December 6, 2003
["Kidney transplantation" Professional Group of the Graduate and Continuing Education Committee of German Urologists. Report of the 10th annual meeting of the Professional Group 27 - 29 June 2002 in Halle/Saale]H Loertzer, H Heynemann, K Dreikorn, et al.
Urology|May 19, 2001
Do bacteriostatic urethral lubricants affect the clinical efficacy of intravesical bacillus Calmette-Guérin therapy?H Loertzer, M Brake, R Horsch, et al.
Der Urologe. Ausg. A|May 8, 2002
[Postischemic reperfusion injury. Biochemical and methodological principles]H J Brömme, H Loertzer, Z Akçetin
The Journal of Urology|May 8, 2000
Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-GuerinM Brake, H Loertzer, R Horsch, et al.
Gynecologic and Obstetric Investigation|January 8, 2005
Subcutaneous nephrovesical and nephrocutaneous bypassA Jurczok, H Loertzer, S Wagner, et al.
Urology|May 3, 2000
Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancerM Brake, H Loertzer, R Horsch, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|May 18, 2013
[Stress incontinence in elderly women]H Loertzer, P Schneider
Anticancer Research|July 22, 2005
PSA quick test in capillary bloodH Loertzer, K Fischer, P Fornara
Anticancer Research|July 22, 2005
The use of complexed PSA for the early detection of prostate cancerK Fischer, H Loertzer, P Fornara
Der Urologe. Ausg. A|September 27, 2003
[Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis]H Loertzer, A Jurczok, S Wagner, et al.
Der Urologe. Ausg. A|December 6, 2003
["Kidney transplantation" Professional Group of the Graduate and Continuing Education Committee of German Urologists. Report of the 10th annual meeting of the Professional Group 27 - 29 June 2002 in Halle/Saale]H Loertzer, H Heynemann, K Dreikorn, et al.
Urology|May 19, 2001
Do bacteriostatic urethral lubricants affect the clinical efficacy of intravesical bacillus Calmette-Guérin therapy?H Loertzer, M Brake, R Horsch, et al.
Der Urologe. Ausg. A|May 8, 2002
[Postischemic reperfusion injury. Biochemical and methodological principles]H J Brömme, H Loertzer, Z Akçetin
The Journal of Urology|May 8, 2000
Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-GuerinM Brake, H Loertzer, R Horsch, et al.
Gynecologic and Obstetric Investigation|January 8, 2005
Subcutaneous nephrovesical and nephrocutaneous bypassA Jurczok, H Loertzer, S Wagner, et al.
Urology|May 3, 2000
Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancerM Brake, H Loertzer, R Horsch, et al.
Pageof 4